US$ 25.67
glp-1 agonists muscle loss Weighing the risk of treatment in older adults: Should we be concerned about sarcopenic obesity? Do GLP-1 drugs shrink your
Description
Potcovaru CG, Filip PV, Neagu OM, Diaconu LS, Salmen T, Cintez D, et al

This is especially true of older people and post-menopausal women who are already at high risk for this condition

Nature Reviews Endocrinology , 17(12), 757769

Microvascular effects of the inhibition of dipeptidylpeptidase IV by linagliptin in nondiabetic hypertensive patients
Cell Signal

10 (16), e020301
